X-154352308-C-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001110556.2(FLNA):​c.6642G>C​(p.Val2214Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00985 in 1,210,224 control chromosomes in the GnomAD database, including 718 homozygotes. There are 3,272 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.051 ( 373 hom., 1632 hem., cov: 25)
Exomes 𝑓: 0.0056 ( 345 hom. 1640 hem. )

Consequence

FLNA
NM_001110556.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.64

Publications

3 publications found
Variant links:
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
FLNA Gene-Disease associations (from GenCC):
  • periventricular nodular heterotopia
    Inheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • frontometaphyseal dysplasia 1
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • heterotopia, periventricular, X-linked dominant
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
  • intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Melnick-Needles syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • otopalatodigital syndrome type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • terminal osseous dysplasia-pigmentary defects syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • cardiac valvular dysplasia, X-linked
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • frontometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital short bowel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • otopalatodigital syndrome type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Ehlers-Danlos syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant X-154352308-C-G is Benign according to our data. Variant chrX-154352308-C-G is described in ClinVar as Benign. ClinVar VariationId is 93770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.64 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110556.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLNA
NM_001110556.2
MANE Select
c.6642G>Cp.Val2214Val
synonymous
Exon 41 of 48NP_001104026.1
FLNA
NM_001456.4
c.6618G>Cp.Val2206Val
synonymous
Exon 40 of 47NP_001447.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLNA
ENST00000369850.10
TSL:1 MANE Select
c.6642G>Cp.Val2214Val
synonymous
Exon 41 of 48ENSP00000358866.3
FLNA
ENST00000360319.9
TSL:1
c.6618G>Cp.Val2206Val
synonymous
Exon 39 of 46ENSP00000353467.4
FLNA
ENST00000369856.8
TSL:1
c.6561G>Cp.Val2187Val
synonymous
Exon 40 of 47ENSP00000358872.4

Frequencies

GnomAD3 genomes
AF:
0.0510
AC:
5725
AN:
112312
Hom.:
373
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.176
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0167
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0131
Gnomad NFE
AF:
0.000566
Gnomad OTH
AF:
0.0473
GnomAD2 exomes
AF:
0.0141
AC:
2561
AN:
181534
AF XY:
0.00984
show subpopulations
Gnomad AFR exome
AF:
0.185
Gnomad AMR exome
AF:
0.00745
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000541
Gnomad OTH exome
AF:
0.00426
GnomAD4 exome
AF:
0.00562
AC:
6174
AN:
1097852
Hom.:
345
Cov.:
33
AF XY:
0.00451
AC XY:
1640
AN XY:
363426
show subpopulations
African (AFR)
AF:
0.184
AC:
4854
AN:
26401
American (AMR)
AF:
0.00878
AC:
309
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.000295
AC:
16
AN:
54147
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40173
Middle Eastern (MID)
AF:
0.00992
AC:
41
AN:
4132
European-Non Finnish (NFE)
AF:
0.000460
AC:
387
AN:
842117
Other (OTH)
AF:
0.0123
AC:
567
AN:
46088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
293
586
879
1172
1465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0511
AC:
5747
AN:
112372
Hom.:
373
Cov.:
25
AF XY:
0.0471
AC XY:
1632
AN XY:
34680
show subpopulations
African (AFR)
AF:
0.177
AC:
5462
AN:
30910
American (AMR)
AF:
0.0167
AC:
180
AN:
10773
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3512
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2755
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6315
Middle Eastern (MID)
AF:
0.0143
AC:
3
AN:
210
European-Non Finnish (NFE)
AF:
0.000566
AC:
30
AN:
53038
Other (OTH)
AF:
0.0467
AC:
72
AN:
1542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
173
346
519
692
865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0277
Hom.:
161
Bravo
AF:
0.0592
EpiCase
AF:
0.000709
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 09, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 19, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:2
Nov 18, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Apr 20, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
7.7
DANN
Benign
0.68
PhyloP100
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1064822; hg19: chrX-153580676; API